Digital Health Views & Analysis

Views & Analysis

Digital

An overview of AI in pharma – Part 2

According to Takeda Pharmaceuticals, the average time taken to diagnose a rare disease without technology is 7.6 years, and that comes after countless tests and physician visits.

Digital

Could #MedThreads become the new #MedTwitter?

Last month, Meta, the tech giant behind Facebook, Instagram, and WhatsApp, announced the launch of Threads: a direct challenger to its now rebranded rival, X (Twitter).

Digital

Unlocking the potential of autonomous clinical research

Artificial intelligence (AI) technology has revolutionised how we approach life, work, and social interaction.

Digital

An overview of AI in pharma – Part 1

In the dynamic realm of modern pharmaceuticals, the convergence of artificial intelligence (AI) has emerged as a transformative catalyst, propelling companies towards unparalleled competiti

Digital

Frontiers Health 2023: Guiding themes and steering committee

Frontiers Health, a premier global digital health innovation event strongly focused on digital therapeutics, breakthrough technologies, healthcare transformation, investments, and ecosystem

Digital

Why the Next-Gen participant experience starts with technolo...

The clinical trial industry is hyper-focused on enhancing the participant experience. We’ve seen buzzwords like “patient convenience” and marketing campaigns around “patient centricity”.

An overview of AI in pharma – Part 2

Could #MedThreads become the new #MedTwitter?

Unlocking the potential of autonomous clinical research

An overview of AI in pharma – Part 1

Frontiers Health 2023: Guiding themes and steering committee

Why the Next-Gen participant experience starts with technolo...

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks